BioCryst Pharmaceuticals Inc (BCRX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for BCRX. 13F holdings as of 2026-09-30.
In 13F filings for the quarter ended September 30, 2026, 2 institutions reported holding BCRX, with 304,727 shares worth $2.5 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Doliver Advisors | 304,328 | $3M | DECREASED |
| Versant Capital Management | 399 | $3K | DECREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Steven Frank (Director) | AWARD | 1,288 | $12K | 2026-08-31 |
| Amy E Mckee (Director) | AWARD | 644 | $6K | 2026-08-31 |
| Vincent Milano (Director) | AWARD | 1,159 | $11K | 2026-08-31 |
| Jill C. Milne (Director) | AWARD | 1,288 | $12K | 2026-08-31 |
| Jon P Stonehouse (Director) | AWARD | 644 | $6K | 2026-08-31 |
Recent Congressional Trades
| Member | Type | Amount | Date |
|---|---|---|---|
| Gilbert Cisneros (Democrat) | PURCHASE | $1,001 - $15,000 | 2026-07-10 |
| Gilbert Cisneros (Democrat) | PURCHASE | $1,001 - $15,000 | 2026-07-09 |
Full institutional holdings, insider history, and congressional trades for BioCryst Pharmaceuticals Inc on SentiSense.